Epigenetics As a Versatile Regulator of Fibrosis
Overview
General Medicine
Authors
Affiliations
Fibrosis, a process caused by excessive deposition of extracellular matrix (ECM), is a common cause and outcome of organ failure and even death. Researchers have made many efforts to understand the mechanism of fibrogenesis and to develop therapeutic strategies; yet, the outcome remains unsatisfactory. In recent years, advances in epigenetics, including chromatin remodeling, histone modification, DNA methylation, and noncoding RNA (ncRNA), have provided more insights into the fibrotic process and have suggested the possibility of novel therapy for organ fibrosis. In this review, we summarize the current research on the epigenetic mechanisms involved in organ fibrosis and their possible clinical applications.
Han S, Ko J, Jung S, Oh S, Kim D, Kang E Exp Mol Med. 2024; 56(12):2617-2630.
PMID: 39617786 PMC: 11671536. DOI: 10.1038/s12276-024-01352-6.
Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A Cell Commun Signal. 2024; 22(1):542.
PMID: 39538298 PMC: 11558984. DOI: 10.1186/s12964-024-01925-y.
Pathogenesis and Therapy of Hermansky-Pudlak Syndrome (HPS)-Associated Pulmonary Fibrosis.
Hu X, Wei Z, Wu Y, Zhao M, Zhou L, Lin Q Int J Mol Sci. 2024; 25(20).
PMID: 39457053 PMC: 11508683. DOI: 10.3390/ijms252011270.
Akkiz H, Gieseler R, Canbay A Int J Mol Sci. 2024; 25(14).
PMID: 39063116 PMC: 11277292. DOI: 10.3390/ijms25147873.
Brandt S, Bernhardt A, Haberer S, Wolters K, Gehringer F, Reichardt C Cells. 2024; 13(5.
PMID: 38474331 PMC: 10930537. DOI: 10.3390/cells13050367.